A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients

NCT00619398 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: Prograf
DRUG: FK506MR capsule

Sponsor

Astellas Pharma Inc